[Retracted] Clinical Diagnostic Value of Quantitative Hepatitis B Virus Core Antibody Test in Chronic Viral Hepatitis B

Table 1

General situation and comparison of various indexes in four periods of chronic HBV infection.

	Immune control period (LR)(n = 73)	Immune tolerance period (IT); (n = 46)	Immune clearance period (IC); (n = 44)	Reactivity period (ENH); (n = 57)
Male/female	46/27	14/32	29/15	38/19
Age	45.47 ± 13.23	31.24 ± 9.06	31.27 ± 9.87	43.14 ± 13.46
HBsAg	122.280 (20.795, 770.290)	>50000.00 (>50000.00, >50000.00)^a	37461.50 (10000.00, >50000.00)^a	4094.80 (1981.48, 8218.79)^abc
HBcAb	5202.91 (2103.58, 21238.87)	7511.24 (1932.52, 20395.84)	39725.54 (11349.75, 67178.47)^ab	39326.22 (14090.12,69366.34)^ab
HBV DNA	102.00 (100.00, 1095.00)	17.25E + 07 (949.25E + 05,293.25E + 06)^a	7.67E + 07 (102.75E + 05, 294.75E + 06)^a	4.2E + 04 (3060, 1.42E + 06)^abc
ALT	21.80 (14.45, 31.80)	27.25 (22.65, 38.68)	144.40(74.48, 276.13)^ab	53.90 (40.70, 180.15)^ab
AST	23.68 (18.95, 28.80)	25.20 (19.60, 30.68)	77.75 (42.40, 145.05)^ab	41.00 (27.30, 93.90)^ab
PLT	205.05 ± 69.67	222.78 ± 65.98	187.35 ± 63.37	192.71 ± 64.41

Note. Compared with the immune control period, ; compared with the immune tolerance period, ; compared with immune clearance period, .